Announce Date | 05/15/2025 |
EPS Normalized Actual | $0.13 (Beat by $0.01) |
EPS GAAP Actual | $0.13 (Beat by $0.01) |
Revenue Actual | $0.54791B |
Revenue Surprise | Beat by $547.91M |
Announce Date | 12/31/1969 (Pre-Market) |
EPS Normalized Estimate | $ |
EPS GAAP Estimate | $ |
Revenue Estimate | $0B |
Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
---|---|---|---|---|---|
Dec 2027 | 1.319 | 3.92 | 1.319 | 1.319 | 0 |
Dec 2026 | 1.34724 | 3.84 | 1.34724 | 1.34724 | 0 |
Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
---|---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.13 | 0.13 | 0.54791B | 100% | 547.91M |
FQ4 2024 (Dec 2024) | 0.15 | 0.15 | 0.532861B | 100% | 532.86M |
FQ3 2024 (Sep 2024) | 0.42 | 0.42 | 0.719731B | 100% | 719.73M |
FQ2 2024 (Jun 2024) | 0.51 | 0.51 | 0.836676B | 42.54% | 836.68M |
FQ3 2021 (Sep 2021) | -0.0572 | -0.0572 | 0.189732B | 100% | 189.73M |
FQ4 2021 (Dec 2021) | -0.0215 | -0.0215 | 0.24166B | 100% | 241.66M |
FQ1 2022 (Mar 2022) | 0.0502 | 0.0502 | 0.268481B | 100% | 268.48M |
FQ2 2022 (Jun 2022) | 0.39 | 0.39 | 0.445531B | 100% | 445.53M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 0.3352 | -- | 0.3352 | 0.3352 | 0 |
FQ3 2027 (Jul 2027) | 0.3269 | -- | 0.3269 | 0.3269 | 0 |
FQ2 2027 (Jun 2027) | 0.3269 | -- | 0.3269 | 0.3269 | 0 |
FQ1 2027 (Mar 2027) | 0.3198 | -- | 0.3198 | 0.3198 | 0 |
FQ4 2026 (Oct 2026) | 0.3154 | -- | 0.3154 | 0.3154 | 0 |
FQ3 2026 (Jul 2026) | 0.3043 | -- | 0.3043 | 0.3043 | 0 |
FQ2 2026 (Jun 2026) | 0.3043 | -- | 0.3043 | 0.3043 | 0 |
FQ1 2026 (Mar 2026) | 0.2972 | 56.26 | 0.2972 | 0.2972 | 0 |
FQ4 2025 (Oct 2025) | 0.20089 | 25.33 | 0.20089 | 0.20089 | 0 |
FQ3 2025 (Sep 2025) | 0.18354 | -128.83 | 0.18354 | 0.18354 | 0 |
Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2027 (Oct 2027) | 2.25B | -- | 2.25B | 2.25B | 0 |
FQ3 2027 (Jul 2027) | 2.08B | -- | 2.08B | 2.08B | 0 |
FQ2 2027 (Jun 2027) | 2.11B | -- | 2.11B | 2.11B | 0 |
FQ1 2027 (Mar 2027) | 1.96B | -- | 1.96B | 1.96B | 0 |
FQ4 2026 (Oct 2026) | 0.29B | -- | 0.29B | 0.29B | 0 |
FQ3 2026 (Jul 2026) | 0.29B | -- | 0.29B | 0.29B | 0 |
FQ2 2026 (Jun 2026) | 0.29B | -- | 0.29B | 0.29B | 0 |
FQ1 2026 (Mar 2026) | 0.28B | -92.52 | 0.28B | 0.28B | 0 |
FQ4 2025 (Oct 2025) | 0.23B | -130.63 | 0.23B | 0.23B | 0 |
FQ3 2025 (Sep 2025) | 0.24B | -194.97 | 0.24B | 0.24B | 0 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
---|---|---|---|---|---|
FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
2
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | 0.13 | 0.13 | 100% | |
FQ4 2024 (Dec 2024) | 0.15 | 0.15 | 100% | |
FQ3 2024 (Sep 2024) | 0.42 | 0.42 | 100% | |
FQ2 2024 (Jun 2024) | 0.51 | 0.51 | 100% | |
FQ3 2021 (Sep 2021) | -0.0572 | -0.0572 | 100% | |
FQ4 2021 (Dec 2021) | -0.0215 | -0.0215 | 100% | |
FQ1 2022 (Mar 2022) | 0.0502 | 0.0502 | 100% | |
FQ2 2022 (Jun 2022) | 0.39 | 0.39 | 100% |
Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
---|---|---|---|---|
FQ1 2025 (Mar 2025) | $0B | $0.55B | $547.91M | 100% |
FQ4 2024 (Dec 2024) | $0B | $0.53B | $532.86M | 100% |
FQ3 2024 (Sep 2024) | $0B | $0.72B | $719.73M | 100% |
FQ2 2024 (Jun 2024) | $0B | $0.84B | $836.68M | 100% |
FQ3 2021 (Sep 2021) | $0B | $0.19B | $189.73M | 100% |
FQ4 2021 (Dec 2021) | $0B | $0.24B | $241.66M | 100% |
FQ1 2022 (Mar 2022) | $0B | $0.27B | $268.48M | 100% |
FQ2 2022 (Jun 2022) | $0B | $0.45B | $445.53M | 100% |